Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
HMGA2 Is a Driver of Tumor Metastasis
2013
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Epothilones – A fascinating family of microtubule stabilizing antitumor agents
2008
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Targeting cancer cells: magnetic nanoparticles as drug carriers
2006
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
2008 StandoutNature
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
2004
Iron/ethylcellulose (core/shell) nanoplatform loaded with 5-fluorouracil for cancer targeting
2010
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The effect of magnetic targeting on the uptake of magnetic-fluid-loaded liposomes by human prostatic adenocarcinoma cells
2008
Enhanced Brain Tumor Selectivity of Cationic Magnetic Polysaccharide Microspheres
1998
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Lung Cancer
2008 Standout
Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles
2006
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Study of carbonyl iron/poly(butylcyanoacrylate) (core/shell) particles as anticancer drug delivery systems
2007
Analytical model of magnetic nanoparticle transport and capture in the microvasculature
2006
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Tegafur loading and release properties of magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles
2007
Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration
2010
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Catalysis for fluorination and trifluoromethylation
2011 StandoutNature
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Gemcitabine Plus Cisplatin for the Treatment of Metastatic Breast Cancer
2002
Development of carbonyl iron/ethylcellulose core/shell nanoparticles for biomedical applications
2007
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Pyruvate kinase type M2 and its role in tumor growth and spreading
2005
Nonresolving Inflammation
2010 Standout
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
2009
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy
2005
Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles
2009
Genetically programmed chiral organoborane synthesis
2017 StandoutNatureNobel
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Magnetic poly ε-caprolactone nanoparticles containing Fe3O4and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model
2007
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Regulation of cancer cell metabolism
2011 Standout
Drug‐Loaded Superparamagnetic Iron Oxide Nanoparticles for Combined Cancer Imaging and Therapy In Vivo
2008
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
2002
Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits
2000
AC-magnetic field controlled drug release from magnetoliposomes: design of a method for site-specific chemotherapy
2002
Emerging Biological Principles of Metastasis
2017 Standout
Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells
2004
Magnetic Colloids As Drug Vehicles
2007
Adjuvant therapy in pancreatic cancer: historical and current perspectives
2003
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment
2004
PVP magnetic nanospheres: Biocompatibility, in vitro and in vivo bleomycin release
2006
Nucleosomes in serum of patients with benign and malignant diseases
2001
Lyophilized Paclitaxel Magnetoliposomes as a Potential Drug Delivery System for Breast Carcinoma via Parenteral Administration: In Vitro and in Vivo Studies
2005
Review: Amyloidogenesis—Unquestioned Answers and Unanswered Questions
2000
Multiple myeloma: evolving genetic events and host interactions
2002
Pancreatic Cancer
2010 Standout
Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector
2005
Magnetofection: Enhancing and Targeting Gene Delivery with Superparamagnetic Nanoparticles and Magnetic Fields
2003
Magnetic Drug Targeting--Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment
2003
Phase II Trial of Gemcitabine plus Trastuzumab in Metastatic Breast Cancer Patients Previously Treated with Chemotherapy: Preliminary Results
2002
Mucormycosis in systemic lupus erythematosus
2003
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
2007 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy
2010
Circulating nucleic acids (CNAs) and cancer—A survey
2006
Treatment of Breast Cancer
1998
Clinical Applications of Magnetic Drug Targeting
2001
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Electromagnetic Heating of Breast Tumors in Interventional Radiology: In Vitro and in Vivo Studies in Human Cadavers and Mice
2001
Effects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermia
2008
Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting
2007
Computational design of ligand-binding proteins with high affinity and selectivity
2013 StandoutNatureNobel
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
2011 StandoutNobel
Molecular Mechanisms of Amyloidosis
2003 Standout
Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging
2008
Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment
2009
Boron Chemicals in Diagnosis and Therapeutics
2013
Fluorine in medicinal chemistry
2007 Standout
Poly(l -lysine)-Modified Iron Oxide Nanoparticles for Stem Cell Labeling
2008
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Proteomics biomarkers for solid tumors: Current status and future prospects
2018
Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
2007
Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology
2005 Standout
Methylene Blue-Containing Silica-Coated Magnetic Particles: A Potential Magnetic Carrier for Photodynamic Therapy
2007
Magnetic targeting for site-specific drug delivery: applications and clinical potential
2009
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
2000
Enhancing and targeting nucleic acid delivery by magnetic force
2003
Recent Advances on Surface Engineering of Magnetic Iron Oxide Nanoparticles and Their Biomedical Applications
2007
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Ligand-Binding Proteins: Their Potential for Application in Systems for Controlled Delivery and Uptake of Ligands
2000
In situ synthesis and magnetic studies of iron oxide nanoparticles in calcium-alginate matrix for biomedical applications
2006
A novel and rapid method for quantification of magnetic nanoparticle–cell interactions using a desktop susceptometer
2004
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
2005
Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications
1999
Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer
2007
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Graphene-Like Two-Dimensional Materials
2013 Standout
Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.
2001
Physiological aspects in magnetic drug-targeting
1999
Prospective Phase II Study of Gefitinib for Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene Mutations
2006
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells
2008
Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy
2004
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
2002
Structural Basis for Tumor Pyruvate Kinase M2 Allosteric Regulation and Catalysis,
2005
Synthesis of aqueous magnetic liquids by surface complexation of maghemite nanoparticles
1999
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma
2002
A novel core-shell structured magnetic organic-inorganic nanohybrid involving drug-intercalated layered double hydroxides coated on a magnesium ferrite core for magnetically controlled drug release
2009
Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles.
2007
Synthesis, properties, and applications of magnetic iron oxide nanoparticles
2008 Standout
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer
2006
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Challenges in the development of magnetic particles for therapeutic applications
2008
Fluorine in medicinal chemistry: A review of anti-cancer agents
2006
Recent Advances in the Synthesis and Application of Layered Double Hydroxide (LDH) Nanosheets
2012 Standout
Visible Light Photoredox Catalysis with Transition Metal Complexes: Applications in Organic Synthesis
2013 Standout
Locoregional cancer treatment with magnetic drug targeting.
2000
Multiple Myeloma
2011 Standout
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
High Mobility Group A2 Potentiates Genotoxic Stress in Part through the Modulation of Basal and DNA Damage–Dependent Phosphatidylinositol 3-Kinase–Related Protein Kinase Activation
2005
Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy
1999
Magnetic nanoparticles for drug delivery
2007
CNS Metastases in Breast Cancer
2004
Modelling magnetic carrier particle targeting in the tumor microvasculature for cancer treatment
2005
Works of K. Possinger being referenced
Randomized Clinical Trial Comparing Mitoxantrone with Epirubicin and with Doxorubicin, each Combined with Cyclophosphamide in the First-Line Treatment of Patients with Metastatic Breast Cancer
1990
Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support
1999
Disseminated Mucormycosis Caused by Absidia corymbifera Leading to Cerebral Vasculitis
2000
Detection of Microsatellite Alterations in the DNA Isolated from Tumor Cells and from Plasma DNA of Patients with Lung Cancer
2000
Clinical Relevance of Soluble c-erbB-2 for Patients with Metastatic Breast Cancer Predicting the Response to Second-Line Hormone or Chemotherapy
2002
CA27.29
2001
Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer
1999
Prediction of Response to Hormonal Treatment in Metastatic Breast Cancer
2002
Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer
2003
A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines
2008
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
2000
Advanced breast cancer: a phase II trial with gemcitabine.
1995
Oral Administration of Idarubicin as First Line Cytostatic Therapy in Patients with Metastasized Breast Cancer and Favourable Prognosis
1991
Endocrine treatment options for advanced breast cancer – the role of fulvestrant
2004
High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Support Compared With Standard-Dose Chemotherapy in Breast Cancer Patients With 10 or More Positive Lymph Nodes: First Results of a Randomized Trial
2004
Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study.
1991
Mucormycoses
2001
A phase I study of the novel, third generation epothilone ZK-EPO in patients with advanced solid tumors
2005
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
1996
Oxidant-induced lung injury in anticancer therapy.
1999
Tumor type M2 pyruvate kinase expression in advanced breast cancer.
2001
Upregulation of HER-2/neu is independent of the menopausal status of primary breast cancer patients: Plasma results from a prospectively randomized trial comparing dose-intense chemotherapy with G-CSF support to 3-weekly chemotherapy for adjuvant therapy of nodal-positive (1–3 LN) breast cancer (German Adjuvant Study Group ASG)
2005
Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy
2001